Skip to main content
MedicHelpLine
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsORALGeneric

MELLARIL

THIORIDAZINE HYDROCHLORIDE

Standard Dose
10MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Max Dose
Refer to approved labeling
Primary Use
Marketing status: Discontinued
Summary

Approval overview MELLARIL is listed in Drugs@FDA under application 011808 (NDA).

Marketing status: Discontinued Active ingredient THIORIDAZINE HYDROCHLORIDE Form and strength TABLET;ORAL - 10MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** Sponsor NOVARTIS Submission history Latest submission status date: 2007-12-07 00:00:00.

Structured Monograph

Clinical summary

Approval overview MELLARIL is listed in Drugs@FDA under application 011808 (NDA). Marketing status: Discontinued Active ingredient THIORIDAZINE HYDROCHLORIDE Form and strength TABLET;ORAL - 10MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** Sponsor NOVARTIS Submission history Latest submission status date: 2007-12-07 00:00:00. Submission type: SUPPL.

Monitoring

  • Marketing status: Discontinued

Interaction Notes

  • No interaction notes stored yet.
MELLARIL (THIORIDAZINE HYDROCHLORIDE) | Drug Monograph | MedicHelpline